Cryoport, Inc. (NASDAQ:CYRX – Get Rating) has received an average recommendation of “Buy” from the seven research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $61.33.
Separately, Needham & Company LLC increased their price objective on Cryoport from $41.00 to $42.00 and gave the stock a “buy” rating in a research note on Tuesday, July 12th.
Insider Buying and Selling at Cryoport
In other news, Director Robert J. Hariri sold 2,000 shares of the firm’s stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $43.29, for a total value of $86,580.00. Following the completion of the transaction, the director now directly owns 7,911 shares of the company’s stock, valued at $342,467.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Richard J. Berman sold 2,708 shares of the stock in a transaction on Tuesday, August 16th. The stock was sold at an average price of $43.05, for a total value of $116,579.40. Following the sale, the director now owns 107,203 shares in the company, valued at $4,615,089.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Robert J. Hariri sold 2,000 shares of the stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $43.29, for a total value of $86,580.00. Following the completion of the sale, the director now owns 7,911 shares in the company, valued at approximately $342,467.19. The disclosure for this sale can be found here. 9.70% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Cryoport
Cryoport Stock Down 7.2 %
Shares of Cryoport stock opened at $29.51 on Friday. Cryoport has a one year low of $19.82 and a one year high of $86.30. The company has a debt-to-equity ratio of 0.73, a current ratio of 14.21 and a quick ratio of 13.69. The stock’s 50-day moving average is $36.07 and its 200 day moving average is $31.09. The firm has a market cap of $1.43 billion, a price-to-earnings ratio of -4.78 and a beta of 1.17.
Cryoport (NASDAQ:CYRX – Get Rating) last announced its earnings results on Thursday, August 4th. The consumer goods maker reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.08). Cryoport had a negative net margin of 125.96% and a negative return on equity of 14.43%. The business had revenue of $64.20 million for the quarter, compared to the consensus estimate of $64.58 million. During the same quarter in the previous year, the company earned ($0.16) EPS. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. Equities research analysts anticipate that Cryoport will post -0.78 EPS for the current year.
Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.
- Get a free copy of the StockNews.com research report on Cryoport (CYRX)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.